Sofinnova et al. back €27m series-C for Limflow
A consortium of investors has injected €27m in a series-C funding round for French developer of peripheral endovascular technology Limflow.
More on Expansion
Essling backs Evolucare Group
GP invests in the software company via Essling Expansion, a fund that recently held a first close
Palamon announces roll-over investment into Ober Scharrer
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
Augmentum leads £150m debt and equity round for Iwoca
NIBC and existing investors including Prime also took part in the round for the SME lender
Bessemer leads €30m round for Mambu
Acton Capital, CommerzVentures, Point Nine Capital and Runa Capital also take part
Latest News
Essling backs Evolucare Group
GP invests in the software company via Essling Expansion, a fund that recently held a first close
Naxicap-backed BVA bolts on Doxa
BVA expects to become one of the main market research groups in Europe and reach revenues of €200m
Palamon announces roll-over investment into Ober Scharrer
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
Augmentum leads £150m debt and equity round for Iwoca
NIBC and existing investors including Prime also took part in the round for the SME lender